(Q57905063)

English

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)

scientific article published on 01 July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

P Kosmidis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N Mylonakis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Skarlos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Samantas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Papadimitriou

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Kalophonos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N Pavlidis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Nikolaidis

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Papaconstantinou

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Fountzilas

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

799-805

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol: Twenty Years Later, the Story Unfolds

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008389402580

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008389402580

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57905063&oldid=2174040179"